Search

Search Constraints

You searched for: Author/Creator Petrich, Adam M.

Search Results

1. A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomas. Issue 14 (6th December 2021)

3. Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose‐adjusted EPOCH plus rituximab. Issue 11 (17th August 2017)

4. F‐18 FDG‐PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem‐cell transplantation for relapsed and refractory Hodgkin lymphoma. (15th March 2014)

5. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B‐cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort. Issue 9 (September 2015)

6. Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma. Issue 4 (13th November 2015)

7. Impact of treatment variability on survival in immuno‐competent and immuno‐compromised patients with primary central nervous lymphoma. (17th February 2017)

10. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable. (29th July 2016)